MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing ...
Brain atrophy in multiple sclerosis (MS) reflects progressive neurodegeneration that correlates with disability, cognitive decline and long-term prognosis. Magnetic resonance imaging (MRI) volumetric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results